Understanding CAR-M Technology with Carisma Therapeutics' Dr. Debora Barton

Cell & Gene: The Podcast

English - November 24, 2021 09:00 - 19 minutes - 13.2 MB - ★★★★★ - 35 ratings
Life Sciences Science Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Inside the Gene Therapy for Coronary Artery Disease with XyloCor Therapeutics' Albert Gianchetti

Next Episode: AVROBIO on Patient Advocacy's Role in Clinical Trial Development & Recruitment

We love to hear from our listeners. Send us a message.

Carisma Therapeutics’ Dr. Barton breaks down the latest in CAR-M technology as well as the company's Phase 1 First-in-Human Study of Adenovirally Transduced Anti-HER2 CAR Macrophages in Subjects with HER2 Overexpressing Solid Tumors.